Nuveen Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $29.9M | Buy |
722,155
+229,746
| +47% | +$9.5M | 0.01% | 918 |
|
|
2024
Q3 | $19.2M | Buy |
492,409
+85,290
| +21% | +$3.33M | 0.01% | 1220 |
|
|
2024
Q2 | $13.9M | Buy |
407,119
+95,934
| +31% | +$3.28M | ﹤0.01% | 1368 |
|
|
2024
Q1 | $7.82M | Sell |
311,185
-159,155
| -34% | -$4M | ﹤0.01% | 1746 |
|
|
2023
Q4 | $13.9M | Buy |
470,340
+37,557
| +9% | +$1.11M | ﹤0.01% | 1381 |
|
|
2023
Q3 | $13.7M | Buy |
432,783
+357,183
| +472% | +$11.3M | ﹤0.01% | 1287 |
|
|
2023
Q2 | $1.96M | Buy |
75,600
+3,906
| +5% | +$101K | ﹤0.01% | 2357 |
|
|
2023
Q1 | $1.72M | Sell |
71,694
-1,554
| -2% | -$37.3K | ﹤0.01% | 2397 |
|
|
2022
Q4 | $1.43M | Sell |
73,248
-10,497
| -13% | -$205K | ﹤0.01% | 2523 |
|
|
2022
Q3 | $1.76M | Buy |
83,745
+44,942
| +116% | +$945K | ﹤0.01% | 2459 |
|
|
2022
Q2 | $756K | Sell |
38,803
-36,752
| -49% | -$716K | ﹤0.01% | 2903 |
|
|
2022
Q1 | $1.67M | Buy |
75,555
+64,535
| +586% | +$1.43M | ﹤0.01% | 2586 |
|
|
2021
Q4 | $150K | Hold |
11,020
| – | – | ﹤0.01% | 3262 |
|
|
2021
Q3 | $199K | Hold |
11,020
| – | – | ﹤0.01% | 3278 |
|
|
2021
Q2 | $191K | Sell |
11,020
-3,300
| -23% | -$57.2K | ﹤0.01% | 3250 |
|
|
2021
Q1 | $284K | Sell |
14,320
-10,491
| -42% | -$208K | ﹤0.01% | 3183 |
|
|
2020
Q4 | $433K | Sell |
24,811
-135
| -0.5% | -$2.36K | ﹤0.01% | 3073 |
|
|
2020
Q3 | $481K | Buy |
24,946
+14,550
| +140% | +$281K | ﹤0.01% | 2966 |
|
|
2020
Q2 | $202K | Buy |
+10,396
| New | +$202K | ﹤0.01% | 3101 |
|